首页> 外文OA文献 >Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS:A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies

【2h】

Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS:A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies

机译：成年男性既有贮尿又有排尿的情况下，单药联合索非那新+坦索罗辛OCAS™联合治疗长达一年的尿retention留发生率：NEPTUNE / NEPTUNE II随机对照研究的亚分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Drake, Marcus J.; Oelke, Matthias; Snijder, Robert; Klaver, Monique; Traudtner, Klaudia; Van Charldorp, Karin; Bongaerts, Dominique; Van Kerrebroeck, Philip;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献

1. Re: Long-Term Safety and Efficacy of Single-Tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-Label Extension Editorial Comment [J] . Kaplan Steven A. The Journal of Urology . 2016,第2期

机译：Re：在储存和排尿下泌尿道症状的男性中单片和Tamsulosin口腔控制吸收系统单片组合的长期安全性和功效：海王星研究和海王星II开放标签扩展的结果
2. Re: Long-Term Safety and Efficacy of Single-Tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-Label Extension Editorial Comment [J] . Kaplan Steven A. The Journal of Urology . 2016,第2期

机译：Re：在储存和排尿下泌尿道症状的男性中单片和Tamsulosin口腔控制吸收系统单片组合的长期安全性和功效：海王星研究和海王星II开放标签扩展的结果
3. Long-term Safety and Efficacy of Single-tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-label Extension [J] . Drake Marcus J., Chapple Christopher, Sokol Roman, European urology . 2015,第2期

机译：索非那新和坦索罗辛口服控制吸收系统单片组合在患有并伴有下尿路症状的男性中的长期安全性和有效性：NEPTUNE研究和NEPTUNE II开放标签扩展的结果
4. Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies [O] . Marcus J. Drake, Matthias Oelke, Robert Snijder, -1

机译：成年男性既有贮尿又有排尿的单用索非那新+坦索罗辛OCAS™单片组合治疗期间尿retention留的发生率：NEPTUNE / NEPTUNE II随机对照研究的亚分析
5. Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies. [O] . Marcus J Drake, Matthias Oelke, Robert Snijder, 2017

机译：在存储和排尿的成年男性中，使用索利那新+坦索罗辛OCas™的单一片剂组合治疗期间尿潴留的发生率持续长达1年LUTs：对NEpTUNE / NEpTUNE II随机对照研究的亚组分析。

Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS:A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies

著录项

相似文献

相关主题

期刊订阅